Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139

1.

Recombinant human thrombopoietin promotes platelet engraftment after haploidentical hematopoietic stem cell transplantation: a prospective randomized controlled trial.

Han TT, Xu LP, Liu DH, Liu KY, Wang FR, Wang Y, Yan CH, Chen YH, Sun YQ, Ji Y, Wang JZ, Zhang XH, Huang XJ.

Ann Hematol. 2015 Jan;94(1):117-28. doi: 10.1007/s00277-014-2158-1. Epub 2014 Jul 30.

PMID:
25069650
2.

Platelet engraftment in patients with hematologic malignancies following unmanipulated haploidentical blood and marrow transplantation: effects of CD34+ cell dose and disease status.

Chang YJ, Xu LP, Liu DH, Liu KY, Han W, Chen YH, Yu-Wang, Chen H, Wang JZ, Zhang XH, Zhao XY, Huang XJ.

Biol Blood Marrow Transplant. 2009 May;15(5):632-8. doi: 10.1016/j.bbmt.2009.02.001.

3.

Effect of c-mpl ligands after total body irradiation (TBI) with and without allogeneic hematopoietic stem cell transplantation: low-dose TBI does not prevent sensitization.

Nash RA, Takatu A, Feng Z, Slichter S, Abrams K, Espino G, Gass MJ, Georges GE, McSweeney PA, Shulman HM, Storb R.

Biol Blood Marrow Transplant. 2002;8(7):360-7.

PMID:
12171482
4.

[Clinical study on platelet engraftment by thrombopoietin in patients with hematological malignancies after allogeneic hematopoietic stem cell transplantation].

Miao M, Wu DP, Cao XS, Dong WM, Wang B, Ou YJ, Li ZY, Li DP, Yang MZ.

Zhonghua Xue Ye Xue Za Zhi. 2012 May;33(5):362-5. Chinese.

PMID:
22781792
5.

A phase I trial of recombinant human thrombopoietin in patients with delayed platelet recovery after hematopoietic stem cell transplantation.

Nash RA, Kurzrock R, DiPersio J, Vose J, Linker C, Maharaj D, Nademanee AP, Negrin R, Nimer S, Shulman H, Ashby M, Jones D, Appelbaum FR, Champlin R.

Biol Blood Marrow Transplant. 2000;6(1):25-34.

6.

The impact of CD34+ cell dose on platelet engraftment in pediatric patients following unmanipulated haploidentical blood and marrow transplantation.

Chang YJ, Xu LP, Liu DH, Liu KY, Han W, Chen YH, Wang Y, Chen H, Wang JZ, Zhang XH, Zhao XY, Huang XJ.

Pediatr Blood Cancer. 2009 Dec;53(6):1100-6. doi: 10.1002/pbc.22159.

PMID:
19743519
7.

Unmanipulated HLA-mismatched/haploidentical peripheral blood stem cell transplantation for high-risk hematologic malignancies.

Huang W, Li H, Gao C, Bo J, Wang Q, Zhao Y, Jing Y, Wang S, Zhu H, Dou L, Wang L, Yu L.

Transfusion. 2012 Jun;52(6):1354-62. doi: 10.1111/j.1537-2995.2011.03478.x. Epub 2012 Jan 10.

PMID:
22233440
8.

Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.

Chen XH, Zhang C, Zhang X, Gao L, Gao L, Kong PY, Peng XG, Qi DG, Sun AH, Zeng DF, Liu H, Gong Y, Wang QY.

Biol Blood Marrow Transplant. 2009 Feb;15(2):266-73. doi: 10.1016/j.bbmt.2008.11.029. Erratum in: Biol Blood Marrow Transplant. 2009 Apr;15(4):521.

9.

High CD34+ cell dose promotes faster platelet recovery after autologous stem cell transplantation for acute myeloid leukemia.

Gunn N, Damon L, Varosy P, Navarro W, Martin T, Ries C, Linker C.

Biol Blood Marrow Transplant. 2003 Oct;9(10):643-8.

10.

Recombinant human thrombopoietin in combination with granulocyte colony-stimulating factor enhances mobilization of peripheral blood progenitor cells, increases peripheral blood platelet concentration, and accelerates hematopoietic recovery following high-dose chemotherapy.

Somlo G, Sniecinski I, ter Veer A, Longmate J, Knutson G, Vuk-Pavlovic S, Bhatia R, Chow W, Leong L, Morgan R, Margolin K, Raschko J, Shibata S, Tetef M, Yen Y, Forman S, Jones D, Ashby M, Fyfe G, Hellmann S, Doroshow JH.

Blood. 1999 May 1;93(9):2798-806.

12.

[The kinetics and prognosis of platelet reconstitution after unmanipulated haploidentical stem cell transplantation without in vitro T cell depletion].

Sun YQ, Zhang XH, Liu DH, Xu LP, Liu KY, Huang XJ.

Zhonghua Xue Ye Xue Za Zhi. 2013 Aug;34(8):664-8. doi: 10.3760/cma.j.issn.0253-2727.2013.08.005. Chinese.

PMID:
23978016
13.

Recombinant human thrombopoietin (rhTPO) after autologous bone marrow transplantation: a phase I pharmacokinetic and pharmacodynamic study.

Wolff SN, Herzig R, Lynch J, Ericson SG, Greer JP, Stein R, Goodman S, Benyunes MC, Ashby M, Jones DV Jr, Fay J.

Bone Marrow Transplant. 2001 Feb;27(3):261-8.

14.

CD41+ and CD42+ hematopoietic progenitor cells may predict platelet engraftment after allogeneic peripheral blood stem cell transplantation.

Demirer T, Ilhan O, Arat M, Genç Y, Ozcan M, Dalva K, Celebi H, Beksaç M, Akan H, Gürman G, Konuk N, Uysal A, Arslan O, Koç H.

J Clin Apher. 2001;16(2):67-73.

PMID:
11746531
15.

Comparison of outcomes after two standards-of-care reduced-intensity conditioning regimens and two different graft sources for allogeneic stem cell transplantation in adults with hematologic diseases: a single-center analysis.

Le Bourgeois A, Mohr C, Guillaume T, Delaunay J, Malard F, Loirat M, Peterlin P, Blin N, Dubruille V, Mahe B, Gastinne T, Le Gouill S, Moreau P, Mohty M, Planche L, Lode L, Bene MC, Chevallier P.

Biol Blood Marrow Transplant. 2013 Jun;19(6):934-9. doi: 10.1016/j.bbmt.2013.03.009. Epub 2013 Mar 21.

16.

Recombinant human thrombopoietin is an effective treatment for thrombocytopenia in hemophagocytic lymphohistiocytosis.

Wang Y, Wang Z, Wu L, Zhang J, Wang J, Yan L.

Ann Hematol. 2013 Dec;92(12):1695-9. doi: 10.1007/s00277-013-1819-9. Epub 2013 Jun 19.

PMID:
23778995
17.

Recombinant human thrombopoietin augments mobilization of peripheral blood progenitor cells for autologous transplantation.

Linker C, Anderlini P, Herzig R, Christiansen N, Somlo G, Bensinger W, Fay J, Lynch JP, Goodnough LT, Ashby M, Benyunes MC, Jones DV, Yang TA, Miller LL, Weaver C.

Biol Blood Marrow Transplant. 2003 Jun;9(6):405-13.

18.

[Correlation between CD34+CD61+ megakaryocyte precursors and platelet engraftment in allogeneic hematopoietic stem cell transplantation].

Zhou LK, Chen HR, Wang HX, Yan HM, Duan LN, Zhu L, Xue M, Liu J, Ji SQ.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008 Dec;16(6):1344-9. Chinese.

PMID:
19099641
19.

Coinfusion of mesenchymal stromal cells facilitates platelet recovery without increasing leukemia recurrence in haploidentical hematopoietic stem cell transplantation: a randomized, controlled clinical study.

Liu K, Chen Y, Zeng Y, Xu L, Liu D, Chen H, Zhang X, Han W, Wang Y, Zhao T, Wang J, Wang J, Han Q, Zhao C, Huang X.

Stem Cells Dev. 2011 Oct;20(10):1679-85. doi: 10.1089/scd.2010.0447. Epub 2011 Feb 5.

PMID:
21142788
20.

[CD34+ cell dose and hematologic recovery in allogeneic peripheral blood stem cell transplantation].

Sawada H, Wake A, Yamasaki Y, Izumi Y.

Rinsho Ketsueki. 2000 Jun;41(6):500-6. Japanese.

PMID:
10921350

Supplemental Content

Support Center